Lowers the risk of cardiovascular mortality. ANDA 77739, held by Aurobindo Pharma. Metoprolol Tartrate.
As of Nov 22, 2026, ANDA 77739 (Metoprolol Tartrate), held by Aurobindo Pharma, was first approved by FDA on Sep 11, 2007, with 9 approved supplements and 0 published complete response letters.
Metoprolol tartrate tablets are a beta-adrenergic blocker indicated for the treatment of: Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. Angina Pectoris. Myocardial Infarction, to reduce the risk of cardiovascular mortality when used in conjunction with intravenous metoprolol therapy in patients with definite or suspected acute myocardial infarction in hemodynamically stable patients. 1.1 Hypertension Metoprolol tartrate tablets are indicated for the treatment of hypertension in adult patients, to lower blood pressure.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 11, 2007 | Original application | Approved | None posted |
| Metoprolol Tartrate25MG ยท tablet;oral | Metoprolol Tartrate | Rx |
| Metoprolol Tartrate50MG ยท tablet;oral | Metoprolol Tartrate | Rx |
| Metoprolol Tartrate100MG ยท tablet;oral | Metoprolol Tartrate | Rx |
| Metoprolol Tartrate37.5MG ยท tablet;oral | Metoprolol Tartrate | Rx |
| Metoprolol Tartrate75MG ยท tablet;oral | Metoprolol Tartrate | Rx |
| Nov 22, 2023 | Supplement 30Labeling ยท Standard review | Approved | None posted |
| Sep 8, 2015 | Supplement 13Labeling ยท Standard review | Approved | None posted |
| Jul 19, 2014 | Supplement 8Manufacturing | Approved | None posted |
| Mar 18, 2013 | Supplement 11Labeling ยท Standard review | Approved | None posted |
| Mar 18, 2013 | Supplement 9Labeling | Approved | None posted |
| Mar 12, 2010 | Supplement 7Labeling | Approved | None posted |
| Feb 26, 2009 | Supplement 5Labeling | Approved | None posted |
| Sep 15, 2008 | Supplement 3Labeling | Approved | None posted |
| Sep 15, 2008 | Supplement 2Labeling | Approved | None posted |
| Sep 11, 2007 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. โWhat FDA's review saysโ is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters